Basic Information
| LncRNA/CircRNA Name | SNHG16 |
| Synonyms | NA |
| Region | GRCh38_17:76557766-76565348 |
| Ensemble | ENSG00000163597 |
| Refseq | NR_038108 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | gemcitabine | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | pancreatic cancer |
| ICD-0-3 | C25 |
| Methods | qPCR |
| Sample | PC tissues,PC human cell lines (BxPC-3, SW1990, PANC-1 and AsPC1) and pancreatic duct epithelial cell line (HPDE6-C7) |
| Expression Pattern | up-regulated |
| Function Description | LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p,SNHG16 is up-regulated in human PC and is associated with poor survival.( |
| Pubmed ID | 30981105 |
| Year | 2019 |
| Title | LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p. |
External Links
| Links for SNHG16 | GenBank HGNC NONCODE |
| Links for pancreatic cancer | OMIM COSMIC |